<DOC>
	<DOCNO>NCT00619229</DOCNO>
	<brief_summary>Evaluation efficacy alprostadil ( prostaglandin E1 ) treatment patient suffer dry age-related macula degeneration</brief_summary>
	<brief_title>Alprostadil Maculopathy Study ( AIMS )</brief_title>
	<detailed_description>Results plan interim analysis indicate number originally plan patient sufficient reach statistical significance primary end point . Instead increase sample size accordingly , decide terminate study plan future proceeding base careful analysis unblinded result .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Alprostadil</mesh_term>
	<criteria>Male female subject older 50 year age . Dry agerelated macula degeneration ( AMD ) hard drusen possibly begin geographic atrophy one eye Visual acuity 0.2 0.7 ( logMAR ) assess ETDRS chart Dry AMD AREDS category 3 4 eye Wet AMD least one eye Detachment pigmentary epithelium Glaucoma Diabetic retinopathy Medical history retinal vein occlusion Uveitis Cataract surgery study High myopia ( &lt; 6 dpt ) pathological finding retina Medical history opthalmic surgery complication Medical history cataract surgery without complication within last 12 week Medical history vitrectomy AREDS medication within last 2 day Opthalmologic dietary supplement within last 2 day Medical history retinal hemorrhage Cardiac failure ( NYHA grade II high ) Inadequately control coronary heart disease cardiac arrhythmia Subject medical history and/or suspicion pulmonary edema pulmonary infiltration Subject peripheral edema Myocardial infarction within 6 month prior enrollment Subject renal insufficiency , compensate retention ( creatinine &gt; 1,5 mg/dL ) Subject know exist malignant disease Severe chronic obstructive pulmonary disease Subject venoocclusive lung disease Known hepatic disease Inadequately control untreated hypertension ( systolic blood pressure ≥ 180 mmHg , diastolic blood pressure ≥ 110 mmHg ) Subject upper grade cardiac valvular disorder Pregnancy lactation period Known hypersensitivity PGE1 component trial medication Subject history chronic alcohol drug abuse within past 2 year Subject know lactose intolerance Poor general state health criterion Subject serious illness Laboratory value outside normal range unless consider clinically relevant investigator</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Alprostadil</keyword>
	<keyword>prostaglandin E1</keyword>
	<keyword>Prostavasin®</keyword>
	<keyword>macular degeneration</keyword>
</DOC>